Short answer · Medically reviewed summary · Last updated: 2026-05-08
HFE hereditary haemochromatosis was first clinically described by Armand Trousseau in 1865 and later characterized by Friedrich Daniel von Recklinghausen in 1889 as "bronze diabetes." Our modern understanding transformed in 1996 when the HFE gene was identified, shifting the condition from a poorly understood iron-storage mystery to a clearly defined genetic disorder. When was HFE hereditary haemochromatosis first described? The clinical history of HFE hereditary haemochromatosis began in the 19th century. In 1865, Armand Trousseau noted the link between skin pigmentation and diabetes, though he did not yet understand the role of iron.
6 people with HFE hereditary haemochromatosis have shared their first-person experience on this question at DiseaseMaps.
What is the history of HFE hereditary haemochromatosis?
History of HFE hereditary haemochromatosis: when and how it was discovered, and the milestones in research since, medically reviewed.
HFE hereditary haemochromatosis was first clinically described by Armand Trousseau in 1865 and later characterized by Friedrich Daniel von Recklinghausen in 1889 as "bronze diabetes." Our modern understanding transformed in 1996 when the HFE gene was identified, shifting the condition from a poorly understood iron-storage mystery to a clearly defined genetic disorder.
When was HFE hereditary haemochromatosis first described?
The clinical history of HFE hereditary haemochromatosis began in the 19th century. In 1865, Armand Trousseau noted the link between skin pigmentation and diabetes, though he did not yet understand the role of iron. It was Friedrich Daniel von Recklinghausen who, in 1889, coined the term "haemochromatosis" after observing iron deposits in the tissues of a patient during an autopsy. For decades, it was often misidentified or grouped with other liver conditions.
How did the discovery of the HFE gene change medicine?
The most significant leap in the history of HFE hereditary haemochromatosis occurred in 1996, when researchers at Mercator Genetics identified the HFE gene on chromosome 6. This discovery proved that HFE hereditary haemochromatosis is an autosomal recessive disorder. Prior to this, diagnosis relied almost entirely on invasive liver biopsies; today, genetic testing allows for early detection before organ damage occurs.
What are the major milestones in treating HFE hereditary haemochromatosis?
The evolution of management for HFE hereditary haemochromatosis has been defined by the shift toward proactive, preventive care. Key historical milestones include:
- 1950s: The establishment of therapeutic phlebotomy (bloodletting) as the gold-standard treatment to deplete iron stores.
- 1980s: The development of standardized protocols for monitoring serum ferritin and transferrin saturation.
- 1996: The identification of the C282Y mutation, which is responsible for the vast majority of cases of HFE hereditary haemochromatosis.
- Modern Era: The adoption of widespread genetic screening and clinical guidelines that emphasize early intervention to prevent liver cirrhosis and cardiomyopathy.
How has patient advocacy shaped the understanding of the disease?
For many years, HFE hereditary haemochromatosis was considered a rare "medical curiosity." Patient advocacy groups have been instrumental in correcting the misconception that it only affects older men, successfully highlighting that it is one of the most common genetic disorders in individuals of Northern European descent. Today, the 828 members of the DiseaseMaps community for HFE hereditary haemochromatosis continue to contribute to this legacy of awareness by sharing lived experiences and supporting ongoing research.
Next steps
- Consult a hematologist or gastroenterologist to discuss genetic testing if you have a family history.
- Monitor your iron markers (ferritin and transferrin saturation) as recommended by your physician.
- Join the DiseaseMaps community to connect with others managing HFE hereditary haemochromatosis.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Hereditary hemochromatosis.
- Orphanet: HFE-related haemochromatosis (ORPHA: 396).
- OMIM (Online Mendelian Inheritance in Man): Hemochromatosis; HFE.
- Iron Disorders Institute: History and clinical overview of hemochromatosis.
It is only in recent years that serious attempts have been made to understand the mechanisms of iron regulation in the body. Until 20 - 30 years ago the condition was considered rare. Many people who died from liver disease due to iron overload were probably misdiagnosed.
In 1997 a major breakthrough occurred when the HFE gene mutation C282Y was identified.
In recent years much more research has occurred to understand the cause, symptoms, diagnosis and prevalence of the condition.
Many countries now have their own national support groups.
In Australia, see www.ha.org.au .
For other countries check the haemochromatosis International website http://haemochromatosis-international.org/
Posted May 21, 2017 by Tony Moorhead 2051
Posted Jun 4, 2017 by bewiki 4317
Posted Jul 22, 2017 by Salena 2001
Posted Jul 23, 2017 by Warbychick 1901
Posted Jul 25, 2017 by Ketil Toska 2051
Posted Aug 2, 2017 by Natalie 2000
